Skip to main content
Journal ArticleOPEN ACCESS

False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States

Clinical and Vaccine Immunology (2012) 19(5) 820-822
DOI: 10.1128/CVI.05696-11
13Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays. Copyright © 2012, American Society for Microbiology.

Cite

CITATION STYLE

APA

Foy, M. C., Thio, C. L., Hwang, H. S., Saulynas, M., Hamilton, J. P., Fine, D. M., & Atta, M. G. (2012). False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States. Clinical and Vaccine Immunology, 19(5), 820–822. https://doi.org/10.1128/CVI.05696-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free